HARBOR-AF: a multicentre, open-label, dose escalation study of the efficacy, safety, and tolerability of budiodarone for the treatment of subjects with paroxysmal atrial fibrillation
31 August 2025 (08:15 - 09:00)
Organised by: 
About the speaker
XYRA, LLC, San Francisco Bay (United States of America)
5 More presentations in this session
Doctor C. Balbi (Zurich, CH)
Doctor T. Ahuja (New York, US)
Mrs M. Hamidzoda (Dushanbe, TJ)
Access the full session
The Event
ESC Congress 2025
31 August 2025
08:15 CET
You may be interested in
Congress Session
